LabCorp(R) Scheduled to Present at the Annual JPMorgan Healthcare Conference Jan 9, 2004 at 2:18 PM EST PDF Version BURLINGTON, N.C., Jan. 9 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the 22nd Annual JPMorgan Healthcare Conference in San Francisco, CA on January 12, 2004 at 10:30 a.m. Pacific Time. A live audio webcast of the presentation will be available via the Company web site at www.labcorp.com . A replay of the audio webcast will be available through April 12, 2004. About LabCorp Laboratory Corporation of America(R) Holdings is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $2.5 billion in 2002, over 24,000 employees nationwide, and more than 200,000 clients, LabCorp offers over 4,000 clinical assays ranging from blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; and DIANON Systems, Inc. based in Stratford, CT. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our growing organization, visit our web site at: www.LabCorp.com . Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2002 and will be included in the Company's Form 10-K for the year ended December 31, 2003, when filed. SOURCE Laboratory Corporation of America Holdings -0- 01/09/2004 /CONTACT: Pamela Sherry, +1-336-436-4855, or Shareholder Direct, +1-800-LAB-0401, both of Laboratory Corporation of America/ /Web site: http://www.labcorp.com / (LH) CO: Laboratory Corporation of America Holdings; JPMorgan Healthcare Conference ST: California, North Carolina IN: HEA MTC SU: MAV CCA JT-LA -- CLF016 -- 5377 01/09/2004 14:16 EST http://www.prnewswire.com
